| 1.565 -0.145 (-8.48%) | 08-12 12:18 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.95 |
1-year : | 2.07 |
| Resists | First : | 1.66 |
Second : | 1.77 |
| Pivot price | 1.62 |
|||
| Supports | First : | 1.5 |
Second : | 1.24 |
| MAs | MA(5) : | 1.68 |
MA(20) : | 1.63 |
| MA(100) : | 1.84  |
MA(250) : | 1.81 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 61.2 |
D(3) : | 74.7 |
| RSI | RSI(14): 42.2 |
|||
| 52-week | High : | 2.97 | Low : | 1.17 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ MDAI ] has closed above bottom band by 33.4%. Bollinger Bands are 46.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 32 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.72 - 1.73 | 1.73 - 1.74 |
| Low: | 1.66 - 1.67 | 1.67 - 1.68 |
| Close: | 1.69 - 1.71 | 1.71 - 1.72 |
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient’s wounds. Its system also includes MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images; and AI-Burn software. Spectral AI, Inc. is headquartered in Dallas, Texas.
Tue, 11 Aug 2026
Spectral AI (NASDAQ:MDAI) Announces Quarterly Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Tue, 11 Aug 2026
MDAI: FDA De Novo clearance drives commercial launch, with improved net loss and strong cash position - TradingView
Tue, 11 Aug 2026
MDAI: FDA De Novo clearance drives commercial launch, with strong cash and BARDA support for rollout - TradingView
Tue, 11 Aug 2026
Spectral AI, Inc. (MDAI) Q2 FY2026 earnings call transcript - Yahoo Finance
Tue, 11 Aug 2026
Spectral AI Announces 2026 Second Quarter Financial Results - The Manila Times
Tue, 11 Aug 2026
Spectral AI (NASDAQ: MDAI) wins FDA De Novo nod but faces revenue drop - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Specialties
|
|
| Shares Out | 32 (M) |
| Shares Float | 28 (M) |
| Held by Insiders | 12.9 (%) |
| Held by Institutions | 15.5 (%) |
| Shares Short | 2,620 (K) |
| Shares Short P.Month | 2,960 (K) |
| EPS | -0.53 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.29 |
| Profit Margin | -82 % |
| Operating Margin | -49.4 % |
| Return on Assets (ttm) | -31.5 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -40.5 % |
| Gross Profit (p.s.) | 0.24 |
| Sales Per Share | 0.53 |
| EBITDA (p.s.) | -0.31 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -12 (M) |
| Levered Free Cash Flow | -1 (M) |
| PE Ratio | -3 |
| PEG Ratio | 0 |
| Price to Book value | -5.67 |
| Price to Sales | 2.97 |
| Price to Cash Flow | -4.16 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|